SMPD1 and exocrine pancreatic carcinoma: Thus, to test this hypothesis and to gain insight about the mechanism both in vitro and in vivo, we determined the activity of the acid sphingomyelinase in murine KC and KPC pancreas carcinoma cells treated with PAPTP, FTY-720 or the combination of PAPTP + FTY-720.